| Issue Date | Title | Author(s) |
| 2022-12 | Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials. | Abdin, A; Schulz, M; Riemer, U; Hadëri, B; Wachter, R; Laufs, U; Bauersachs, J; Kindermann, I; Vukadinović, D; Böhm, M |
| 2022-02-27 | Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia. | Mahfoud, F; Kieble, M; Enners, S; Kintscher, U; Laufs, U; Böhm, M; Schulz, M |
| 2022 | Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021. | Katzmann, JL; Kieble, M; Enners, S; Böhm, M; Mahfoud, F; Laufs, U; Schulz, M |
| 2021-11 | Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave. | Enners, S; Gradl, G; Kieble, M; Böhm, M; Laufs, U; Schulz, M |
| 2021-10 | Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany. | Rudolph, UM; Enners, S; Kieble, M; Mahfoud, F; Böhm, M; Laufs, U; Schulz, M |
| 2020-10 | Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. | Schulz, M; Griese-Mammen, N; Schumacher, PM; Strauch, D; Freudewald, L; Said, A; Tsuyuki, RT; Laufs, U; Kintscher, U; Böhm, M; Mahfoud, F |
| 2020-07-23 | The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial. | Schulz, M; Griese-Mammen, N; Schumacher, PM; Anker, SD; Koehler, F; Ruckes, C; Rettig-Ewen, V; Wachter, R; Trenk, D; Böhm, M; Laufs, U |
| 2020-03 | Letter on 'Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial': reply. | Schulz, M; Griese-Mammen, N; Böhm, M; Laufs, U |
| 2018-09-01 | Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments | Scheltema, MJ; Chang, JI; van den Bos, W; Gielchinsky, I; Nguyen, TV; de Reijke, TM; Siriwardana, AR; Böhm, M; de la Rosette, JJ; Stricker, PD |
| 2018-09-01 | Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy | Scheltema, MJ; Chang, JI; Böhm, M; van den Bos, W; Blazevski, A; Gielchinsky, I; Kalsbeek, AMF; van Leeuwen, PJ; Nguyen, TV; de Reijke, TM; Siriwardana, AR; Thompson, JE; de la Rosette, JJ; Stricker, PD |
| 2018-09 | PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study. | Laufs, U; Griese-Mammen, N; Krueger, K; Wachter, A; Anker, SD; Koehler, F; Rettig-Ewen, V; Botermann, L; Strauch, D; Trenk, D; Böhm, M; Schulz, M |
| 2017-12-01 | A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy | van Leeuwen, PJ; Hayen, A; Thompson, JE; Moses, D; Shnier, R; Böhm, M; Abuodha, M; Haynes, AM; Ting, F; Barentsz, J; Roobol, M; Vass, J; Rasiah, K; Delprado, W; Stricker, PD |
| 2016 | Medication knowledge of patients hospitalized for heart failure at admission and after discharge. | Custodis, F; Rohlehr, F; Wachter, A; Böhm, M; Schulz, M; Laufs, U |
| 2014-01-01 | Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: A prospective study | Thompson, JE; Moses, D; Shnier, R; Brenner, P; Delprado, W; Ponsky, L; Pulbrook, M; Böhm, M; Haynes, AM; Hayen, A; Stricker, PD |
| 2010-01-01 | Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: Analysis of the controlled rosuvastatin multinational trial in heart failure trial (CORONA) | Inglis, SC; McMurray, JJV; Böhm, M; Schaufelberger, M; Van Veldhuisen, DJ; Lindberg, M; Dunselman, P; Hjalmarson, A; Kjekshus, J; Waagstein, F; Wedel, H; Wikstrand, J |
